BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 34112765)

  • 1. LncRNA CTD-2528L19.6 prevents the progression of IPF by alleviating fibroblast activation.
    Chen T; Guo Y; Wang J; Ai L; Ma L; He W; Li Z; Yu X; Li J; Fan X; Gu Y; Liang H
    Cell Death Dis; 2021 Jun; 12(6):600. PubMed ID: 34112765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of long noncoding RNAs and microRNAs in the pathogenesis of idiopathic pulmonary fibrosis.
    Huang C; Yang Y; Liu L
    Physiol Genomics; 2015 Oct; 47(10):463-9. PubMed ID: 26269497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA PFAR contributes to fibrogenesis in lung fibroblasts through competitively binding to miR-15a.
    Sun J; Su W; Zhao X; Shan T; Jin T; Guo Y; Li C; Li R; Zhou Y; Shan H; Sun X; Liang H
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31273058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic analyses identify the anti-fibrotic role of lncRNA TP53TG1 in IPF.
    Sun J; Guo Y; Chen T; Jin T; Ma L; Ai L; Guo J; Niu Z; Yang R; Wang Q; Yu X; Gao H; Zhang Y; Su W; Song X; Ji W; Zhang Q; Huang M; Fan X; Du Z; Liang H
    Cell Death Dis; 2022 Jun; 13(6):525. PubMed ID: 35661695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of lncRNA PFRL prevents pulmonary fibrosis by disrupting the miR-26a/smad2 loop.
    Jiang H; Chen Y; Yu T; Zhao X; Shan H; Sun J; Zhang L; Li X; Shan H; Liang H
    Am J Physiol Lung Cell Mol Physiol; 2018 Oct; 315(4):L563-L575. PubMed ID: 29952219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia and transforming growth factor β1 regulation of long non-coding RNA transcriptomes in human pulmonary fibroblasts.
    Senavirathna LK; Huang C; Pushparaj S; Xu D; Liu L
    Physiol Rep; 2020 Jan; 8(1):e14343. PubMed ID: 31925944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. lncRNA PFAL promotes lung fibrosis through CTGF by competitively binding miR-18a.
    Li X; Yu T; Shan H; Jiang H; Sun J; Zhao X; Su W; Yang L; Shan H; Liang H
    FASEB J; 2018 Oct; 32(10):5285-5297. PubMed ID: 29683732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung myofibroblasts are characterized by down-regulated cyclooxygenase-2 and its main metabolite, prostaglandin E2.
    Gabasa M; Royo D; Molina-Molina M; Roca-Ferrer J; Pujols L; Picado C; Xaubet A; Pereda J
    PLoS One; 2013; 8(6):e65445. PubMed ID: 23755232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of WNT5A in Idiopathic Pulmonary Fibrosis and Its Control by TGF-β and WNT7B in Human Lung Fibroblasts.
    Newman DR; Sills WS; Hanrahan K; Ziegler A; Tidd KM; Cook E; Sannes PL
    J Histochem Cytochem; 2016 Feb; 64(2):99-111. PubMed ID: 26538547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel differences in gene expression and functional capabilities of myofibroblast populations in idiopathic pulmonary fibrosis.
    Walsh SM; Worrell JC; Fabre A; Hinz B; Kane R; Keane MP
    Am J Physiol Lung Cell Mol Physiol; 2018 Nov; 315(5):L697-L710. PubMed ID: 30091381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long intergenic non-coding RNAs regulate human lung fibroblast function: Implications for idiopathic pulmonary fibrosis.
    Hadjicharalambous MR; Roux BT; Csomor E; Feghali-Bostwick CA; Murray LA; Clarke DL; Lindsay MA
    Sci Rep; 2019 Apr; 9(1):6020. PubMed ID: 30988425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Long Noncoding RNA DNM3OS Is a Reservoir of FibromiRs with Major Functions in Lung Fibroblast Response to TGF-β and Pulmonary Fibrosis.
    Savary G; Dewaeles E; Diazzi S; Buscot M; Nottet N; Fassy J; Courcot E; Henaoui IS; Lemaire J; Martis N; Van der Hauwaert C; Pons N; Magnone V; Leroy S; Hofman V; Plantier L; Lebrigand K; Paquet A; Lino Cardenas CL; Vassaux G; Hofman P; Günther A; Crestani B; Wallaert B; Rezzonico R; Brousseau T; Glowacki F; Bellusci S; Perrais M; Broly F; Barbry P; Marquette CH; Cauffiez C; Mari B; Pottier N
    Am J Respir Crit Care Med; 2019 Jul; 200(2):184-198. PubMed ID: 30964696
    [No Abstract]   [Full Text] [Related]  

  • 13. The lncRNA H19 Mediates Pulmonary Fibrosis by Regulating the miR-196a/COL1A1 Axis.
    Lu Q; Guo Z; Xie W; Jin W; Zhu D; Chen S; Ren T
    Inflammation; 2018 Jun; 41(3):896-903. PubMed ID: 29411215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA Hoxaas3 promotes lung fibroblast activation and fibrosis by targeting miR-450b-5p to regulate Runx1.
    Lin S; Zhang R; Xu L; Ma R; Xu L; Zhu L; Hu J; An X
    Cell Death Dis; 2020 Aug; 11(8):706. PubMed ID: 32848140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-144-3p targets relaxin/insulin-like family peptide receptor 1 (RXFP1) expression in lung fibroblasts from patients with idiopathic pulmonary fibrosis.
    Bahudhanapati H; Tan J; Dutta JA; Strock SB; Sembrat J; Àlvarez D; Rojas M; Jäger B; Prasse A; Zhang Y; Kass DJ
    J Biol Chem; 2019 Mar; 294(13):5008-5022. PubMed ID: 30709904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cartilage oligomeric matrix protein in idiopathic pulmonary fibrosis.
    Vuga LJ; Milosevic J; Pandit K; Ben-Yehudah A; Chu Y; Richards T; Sciurba J; Myerburg M; Zhang Y; Parwani AV; Gibson KF; Kaminski N
    PLoS One; 2013; 8(12):e83120. PubMed ID: 24376648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomodulation by mesenchymal stem cells in treating human autoimmune disease-associated lung fibrosis.
    Liu M; Zeng X; Wang J; Fu Z; Wang J; Liu M; Ren D; Yu B; Zheng L; Hu X; Shi W; Xu J
    Stem Cell Res Ther; 2016 Apr; 7(1):63. PubMed ID: 27107963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long Non-coding RNAs Are Central Regulators of the IL-1β-Induced Inflammatory Response in Normal and Idiopathic Pulmonary Lung Fibroblasts.
    Hadjicharalambous MR; Roux BT; Feghali-Bostwick CA; Murray LA; Clarke DL; Lindsay MA
    Front Immunol; 2018; 9():2906. PubMed ID: 30619270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Periostin plays a critical role in the cell cycle in lung fibroblasts.
    Yoshihara T; Nanri Y; Nunomura S; Yamaguchi Y; Feghali-Bostwick C; Ajito K; Murakami S; Mawatari M; Izuhara K
    Respir Res; 2020 Jan; 21(1):38. PubMed ID: 32000779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-γ enhances the antifibrotic effects of pirfenidone by attenuating IPF lung fibroblast activation and differentiation.
    Vu TN; Chen X; Foda HD; Smaldone GC; Hasaneen NA
    Respir Res; 2019 Sep; 20(1):206. PubMed ID: 31511015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.